SPIEF-2023. The Regulatory Response to Economic Sanctions: New Mechanisms Vital for Future Development of the Pharmaceutical Industry. From left: Sergei Glagolev, Deputy Minister of Health of the Russian Federation, and Aleksandr Petrov, Head of the Expert Council for Regulating the Circulation of Medicines and Medical Devices, Committee of the State Duma of the Federal Assembly of the Russian Federation on Health Protection.14 June#8455723
SPIEF-2023. The Regulatory Response to Economic Sanctions: New Mechanisms Vital for Future Development of the Pharmaceutical Industry. Valentina Kosenko, General Director, Scientific Center for Expertise of Medicinal Products of the Ministry of the Ministry of Health of the Russian Federation.14 June#8455749
SPIEF-2023. The Regulatory Response to Economic Sanctions: New Mechanisms Vital for Future Development of the Pharmaceutical Industry. From left: Dmitriy Galkin, Director of Department of Pharmaceutical and Medical Industry Development, Ministry of Industry and Trade of the Russian Federation, and Valentina Kosenko, General Director, Scientific Center for Expertise of Medicinal Products of the Ministry of the Ministry of Health of the Russian Federation14 June#8455754
SPIEF-2023. The Regulatory Response to Economic Sanctions: New Mechanisms Vital for Future Development of the Pharmaceutical Industry. Aleksandr Petrov, Head of the Expert Council for Regulating the Circulation of Medicines and Medical Devices, Committee of the State Duma of the Federal Assembly of the Russian Federation on Health Protection.14 June#8455700
SPIEF-2023. The Regulatory Response to Economic Sanctions: New Mechanisms Vital for Future Development of the Pharmaceutical Industry.14 June#8455732
SPIEF-2023. The Regulatory Response to Economic Sanctions: New Mechanisms Vital for Future Development of the Pharmaceutical Industry. Yevgeniya Shapiro, Director General, PSK Pharma.14 June#8455713
SPIEF-2023. The Regulatory Response to Economic Sanctions: New Mechanisms Vital for Future Development of the Pharmaceutical Industry.14 June#8455669
SPIEF-2023. The Regulatory Response to Economic Sanctions: New Mechanisms Vital for Future Development of the Pharmaceutical Industry. Dmitriy Galkin, Director of Department of Pharmaceutical and Medical Industry Development, Ministry of Industry and Trade of the Russian Federation.14 June#8455693
SPIEF-2023. The Regulatory Response to Economic Sanctions: New Mechanisms Vital for Future Development of the Pharmaceutical Industry. Yevgeniya Shapiro, Director General, PSK Pharma.14 June#8455630
SPIEF-2023. The Regulatory Response to Economic Sanctions: New Mechanisms Vital for Future Development of the Pharmaceutical Industry. Aleksandr Petrov, Head of the Expert Council for Regulating the Circulation of Medicines and Medical Devices, Committee of the State Duma of the Federal Assembly of the Russian Federation on Health Protection.14 June#8455654
SPIEF-2023. The regulatory response to economic sanctions: new mechanisms vital for future development of the pharmaceutical industry. Valentina Kosenko, General Director, Scientific Center for Expertise of Medicinal Products of the Ministry of the Ministry of Health of the Russian Federation.14 June#8455623
SPIEF-2023. The Regulatory Response to Economic Sanctions: New Mechanisms Vital for Future Development of the Pharmaceutical Industry. Sergey Glagolev, Deputy Minister of Health of the Russian Federation.14 June#8455648
SPIEF-2023. The Regulatory Response to Economic Sanctions: New Mechanisms Vital for Future Development of the Pharmaceutical Industry.14 June#8455611
